Massmutual Trust CO Fsb Cti Biopharma Corp Transaction History

Massmutual Trust CO Fsb

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 07, 2022	SELL	$3.55 - $6.27 $173 - $307	-49 Closed	0 $0
Q1 2022 Apr 08, 2022	BUY	$1.9 - $5.23 $93 - $256	49 New	49 $0
Q4 2018 Feb 26, 2019	SELL	$0.73 - $2.19 $14 - $43	-20 Closed	0 $0
Q4 2017 Mar 01, 2018	SELL	$2.47 - $3.34 $12,648 - $17,104	-5,121 Reduced 99.61%	20 $54,000
Q4 2017 Feb 21, 2018	BUY	$2.47 - $3.34 $12,648 - $17,104	5,121 Added 25605.0%	5,141 $675 Million
Q2 2017 Aug 14, 2017	BUY	N/A	20	20 $66,000

Ticker CTIC
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 114,385,000
Market Cap $1.04B
Description
CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...

Get notified when there are updates to the investment portfolio of Massmutual Trust CO Fsb, based on Form 13F filings with the SEC.

Stay updated on Massmutual Trust CO Fsb with notifications on news.